Percutaneous Cholecystostomy and the Prognosis of Patients with Acute Cholecystitis

Eyal Leibovitz, Lia Shibanov and Mordechai Shimonov

Department of Internal Medicine "A", Yoseftal Hospital, Israel
Department of Surgery "A", Wolfson Medical Center, Israel
Sackler School of Medicine, Tel Aviv University, Israel

^*Correspondance to: Mordechai Shimonov 

 PDF  Full Text Research Article | Open Access

Abstract:

Our objective was to examine outcomes of Percutaneous Cholecystostomy (PC) in patients hospitalized for acute cholecystitis. We compared clinical profiles, length of hospital stay and survival between patients with acute calculus cholecystitis who did (n=50) and did not (n=633) undergo percutaneous cholecystostomy. Those who underwent PC were older and with a poorer clinical profile; and their 30-day and 1-year mortality rates were higher (10% vs. 0.9%, and 20% vs. 4.9%, respectively, p<0.001 for both). In a logistic regression model, PC status was associated with increased 30-day mortality (OR 3.32, 95% CI 0.82-13.43, p=0.09) after adjustment for age, sex, American Society of Anesthesiologists score, disease severity index and cholecystectomy. The most deleterious effect on hospital stay was observed among patients with moderately severe disease. Percutaneous cholecystostomy should be offered only to very high-risk patients. In patients unresponsive to conservative treatment with moderately severe disease, laparoscopic cholecystectomy is the preferred treatment

Keywords:

Acute cholecystitis; Percutaneous cholecystostomy; Hospitalization; Mortality

Cite the Article:

Leibovitz E, Shibanov L, Shimonov M. Percutaneous Cholecystostomy and the Prognosis of Patients with Acute Cholecystitis. World J Surg Surgical Res. 2019; 2: 1125.